StreetInsider.com News Articles

IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.

Fri, 18 Sep 2026 14:00:00 -0400

AUSTIN, Texas, Sept. 18, 2026 (GLOBE NEWSWIRE) -- via IBN – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) has engaged IBN, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.

MindWave Innovations, a wholly owned subsidiary of Apimeds Pharmaceuticals US, is developing institutional digital asset infrastructure connecting treasury, insurance, tokenized assets and blockchain ecosystems. Its platform combines insured custody, transparent reporting and technology-driven portfolio management to support risk-aware yield on Bitcoin reserves and institutional participation in

IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.

Fri, 18 Sep 2026 14:00:00 -0400

Form 8-K Apimeds Pharmaceuticals For: Sep 10

Fri, 11 Sep 2026 09:11:00 -0400

si-local-file:///var/storage/secattach/20260911/27051201.html

Form 8-K Apimeds Pharmaceuticals For: Aug 19

Fri, 21 Aug 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260821/26962399.html

Form 8-K Apimeds Pharmaceuticals For: Aug 19

Fri, 21 Aug 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260821/26962399.html

Form 10-Q Apimeds Pharmaceuticals For: Jun 30

Fri, 14 Aug 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260814/26931267.html

Form 10-Q Apimeds Pharmaceuticals For: Jun 30

Fri, 14 Aug 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260814/26931267.html

Form 8-K Apimeds Pharmaceuticals For: Aug 05

Thu, 06 Aug 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260806/26885670.html

Form 8-K Apimeds Pharmaceuticals For: Aug 05

Thu, 06 Aug 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260806/26885670.html

MindWave Innovations plans blockchain network and U.S. token listing

Tue, 28 Jul 2026 08:31:06 -0400

MindWave Innovations Inc., a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), announced plans to launch MindChain, a Layer 2 blockchain network, in October 2026, according to a press release issued July 28, 2026.

MindChain is described as an Ethereum Virtual Machine-compatible Layer 2 network that settles transactions on Ethereum. The company claims transactions will confirm in one to two seconds. The network will operate with its own sequencer and validator set.

The company also announced that its NILA token will become available to U.S. users on Webot, a licensed cryptocurrency exchange formerly known as Pionex US, beginning Aug.

MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October

Tue, 28 Jul 2026 08:30:00 -0400

MATAWAN, New Jersey, and GEORGE TOWN, Cayman Islands, July 28, 2026 (GLOBE NEWSWIRE) -- via IBN -- MindWave Innovations Inc., a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) ("MindWave Innovations Inc" or the "Company"), today announced MindChain, the world's first fully insured blockchain. MindChain is an insured, production-grade, EVM-compatible Layer 2 network that will go live in October 2026. It gives the MindWave ecosystem its own network, run by its own sequencer and validator set, while every transaction settles on Ethereum for final security.